Select Publications
Journal articles
2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5
,2015, 'Potential public health benefits of HIV testing occurring at home in Australia', Medical Journal of Australia, 202, pp. 529 - 531, http://dx.doi.org/10.5694/mja14.01210
,2015, 'Effect of testing experience and profession on provider acceptability of rapid HIV testing after implementation in public sexual health clinics in Sydney', HIV Medicine, 16, pp. 280 - 287, http://dx.doi.org/10.1111/hiv.12209
,2015, 'Rapid HIV testing is highly acceptable and preferred among high-risk gay and bisexual men after implementation in Sydney sexual health clinics', PLoS ONE, 10, pp. e0123814, http://dx.doi.org/10.1371/journal.pone.0123814
,2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial', Clinical Infectious Diseases, 60, pp. 1026 - 1032, http://dx.doi.org/10.1093/cid/ciu976
,2014, 'Response to the Modeling Analysis by Katz et al. on the Impact of Replacing Clinic-Based HIV Tests With Home Testing Among Men Who Have Sex With Men in Seattle', Sexually Transmitted Diseases, 41, pp. 319 - 319, http://dx.doi.org/10.1097/OLQ.0000000000000127
,2014, 'Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population', PLoS One, 9, pp. e94062-1 - e94062-8, http://dx.doi.org/10.1371/journal.pone.0094062
,2014, 'Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance', Journal of Virological Methods, 199, pp. 102 - 107, http://dx.doi.org/10.1016/j.jviromet.2014.01.007
,2014, 'Lessons learnt from the first Australian 'pop-up' HIV testing site', Sexual Health, 11, pp. 585 - 586, http://dx.doi.org/10.1071/SH14095
,2013, 'Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa', Journal of the International AIDS Society, 16, http://dx.doi.org/10.7448/IAS.16.1.18580
,2013, 'Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 16, http://dx.doi.org/10.7448/IAS.16.1.18580
,2013, 'Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay', Medical Microbiology and Immunology, 202, pp. 77 - 86, http://dx.doi.org/10.1007/s00430-012-0250-5
,2013, 'Evaluation of a pharmacogenetic test in thailand for abacavir hypersensitivity screening in human immunodeficiency virus infection', Current Pharmacogenomics and Personalized Medicine, 11, pp. 231 - 236, http://dx.doi.org/10.2174/18756921113119990005
,2013, 'Evaluation of an interferon-gamma release assay in children with suspected tuberculosis in Papua New Guinea', Pediatric Infectious Disease Journal, 32, pp. 187 - 189, http://dx.doi.org/10.1097/INF.0b013e31827412fc
,2013, 'Point of care (POCT) testing for human immunodeficiency virus (HIV) infection in Australia: in context', Pathology, 45, pp. S49 - S49, http://dx.doi.org/10.1097/01.pat.0000426834.64317.ab
,2012, 'Evaluation of in-house genotyping assay performance using dried blood spot specimens in the global world health organization laboratory network', Clinical Infectious Diseases, 54, http://dx.doi.org/10.1093/cid/cir982
,2011, 'Development of a clinical algorithm to prioritise HIV testing of hospitalised paediatric patients in a low resource moderate prevalence setting', Archives of Disease in Childhood, 96, pp. 67 - 72, http://dx.doi.org/10.1136/adc.2009.179143
,2010, 'Anal sexually transmitted infections and risk of HIV infection in homosexual men', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 53, pp. 144 - 149, http://dx.doi.org/10.1097/QAI.0b013e3181b48f33
,2010, 'Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status', Drug and Alcohol Dependence, 108, pp. 134 - 137, http://dx.doi.org/10.1016/j.drugalcdep.2009.11.013
,2010, 'Prevalence, incidence and risk factors for pharyngeal gonorrhea in a community-based HIV-negative cohort of homosexual men in Sydney, Australia', Sexually Transmitted Infections, 86, pp. 90 - 96, http://dx.doi.org/10.1136/sti.2009.036814
,2009, 'THE IMPACT OF HIV RISK REDUCTION BEHAVIOURS ON SEXUALLY TRANSMISSIBLE INFECTIONS IN HIV NEGATIVE HOMOSEXUAL MEN', SEXUAL HEALTH, 6, pp. 376 - 376, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271708000086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, Australia', Journal of Infectious Diseases, 200, pp. 1813 - 1819, http://dx.doi.org/10.1086/648376
,2009, 'TREAT Asia Quality Assessment Scheme (TAQAS) to standardise the outcome of HIV genotypic resistance testing in a group of Asian laboratories', Journal of Virological Methods, 159, pp. 185 - 193, http://dx.doi.org/10.1016/j.jviromet.2009.03.016
,2008, 'Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men', Clinical Infectious Diseases, 47, pp. E25 - E27, http://dx.doi.org/10.1086/589299
,2008, 'Prevalence, incidence and risk factors for pharyngeal chlamydia in the community based Health in Men (HIM) cohort of homosexual men in Sydney, Australia', Sexually Transmitted Infections, 84, pp. 361 - 363, http://dx.doi.org/10.1136/sti.2008.032037
,2007, 'Anal sexually transmissible infections as risk factors for HIV seroconversion', SEXUAL HEALTH, 4, pp. 294 - 294, http://dx.doi.org/10.1071/SHv4n4Ab25
,2007, 'High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts', Sexually Transmitted Infections, 83, pp. 397 - 399, http://dx.doi.org/10.1136/sti.2007.025684
,2007, 'Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in homosexual men: implications for HIV prevention', Sexually Transmitted Infections, 83, pp. 113 - 119, http://dx.doi.org/10.1136/sti.2006.021915
,2007, 'Incremental detection of HIV infections by the HIV Antigen/Antibody combination assays: An Australian experience', Journal of Medical Virology, 79, pp. S16 - S22
,2005, 'Cytomegalovirus Viraemia after Allogeneic Transplant: A Prospective Study of a Risk-Adapted Strategy in a Single Transplant Unit.', Blood, 106, pp. 5374 - 5374, http://dx.doi.org/10.1182/blood.v106.11.5374.5374
,2005, 'Cytomegalovirus viraemia after allogeneic transplant: A prospective study of a risk-adapted strategy in a single transplant unit', Blood, 106, pp. 429B - 429B
,2005, 'Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia.', Sexual Health, 2, pp. 13 - 18
,2004, 'Incidence immunoassay for distinguishing recent from established HIV-1infection in therapy-naive populations', AIDS, 18, pp. 2253 - 2259
,2003, 'Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations', Journal of Clinical Microbiology, 41, pp. 227 - 236, http://dx.doi.org/10.1128/JCM.41.1.227-236.2003
,2003, 'Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2', HIV Clinical Trials, 4, pp. 252 - 261
,2003, 'Cytomegalovirus polymerase chain reaction tests can replace endoscopy and biopsy for the initial diagnosis of cytomegalovrius gastrointestinal disease in patients following heart transplantation', CSANZ
,2003, 'False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand', Journal of Clinical Virology, 26, pp. 163 - 169
,2003, 'Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine and nelfinavir before complete HIV type 1 seroconversion', AIDS Research and Human Retroviruses, 19, pp. 189 - 199
,2003, 'No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001', AIDS, 17, pp. 264 - 267
,2003, 'Rates of transmission of antiretroviral drug resistant strains of HIV-1', Journal of Clinical Virology, 26, pp. 153 - 153
,2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine', AIDS Research and Human Retroviruses, 17, pp. 1293 - 1296, http://dx.doi.org/10.1089/088922201750461366
,2001, 'Human herpesvirus 8: a newly described sexually transmissible infection.', Venereology - the Interdisciplinary International Journal of Sexual Health, 14, pp. 174 - 180
,2001, 'Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs', AIDS Research and Human Retroviruses, 17, pp. 487 - 497
,2001, 'Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.', Journal of Infectious Diseases, 183, pp. 736 - 743
,2000, 'Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.', AIDS, 14, pp. 1949 - 1954
,2000, 'Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, 172, pp. 57 - 61
,2000, 'Questions about results reported with potent antiretroviral therapy for human immunodeficiency virus type 1 infection. (Authors¿ reply)', Journal of Infectious Diseases, 181, pp. 1519 - 1520
,2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, 14, pp. 2543 - 2551
,1999, 'Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, pp. 437 - 444
,1999, 'Kaposi¿s sarcoma-associated herpesvirus: a sexually transmissible infection?', Journal of acquired immune deficiency syndrome and human retrovirology, 20, pp. 387 - 393
,